Xue Tian
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 27
-
- Cardiovascular Health and Disease Prevention 15
- Blood Pressure and Hypertension Studies 14
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid 12
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 11
- Acute Ischemic Stroke Management 9
- Ophthalmology top 5%
- Ocular Infections and Treatments 12
-
- Inflammasome and immune disorders 8
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xue Tian
105 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Endocrinology, Diabetes and Metabolism 444
- Cardiology and Cardiovascular Medicine 508
- Nephrology 155
- Epidemiology 467
- Ophthalmology 70
Countries citing papers authored by Xue Tian
This map shows the geographic impact of Xue Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Tian more than expected).
Fields of papers citing papers by Xue Tian
This network shows the impact of papers produced by Xue Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Tian. The network helps show where Xue Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xue Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 24 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 11 | |
| 13 | 2023 | 18 | |
| 14 | 2023 | 14 | |
| 15 | 2023 | 24 | |
| 16 | 2022 | 8 | |
| 17 | 2022 | 7 | |
| 18 | 2022 | 4 | |
| 19 | 2021 | 1 | |
| 20 | 2015 | 49 |
About Xue Tian
Xue Tian is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 116 papers that have together received 1.6k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (27 papers), Cardiovascular Health and Disease Prevention (15 papers), Blood Pressure and Hypertension Studies (14 papers), Ocular Infections and Treatments (12 papers), Gout, Hyperuricemia, Uric Acid (12 papers), Liver Disease Diagnosis and Treatment (11 papers), Acute Ischemic Stroke Management (9 papers) and Inflammasome and immune disorders (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (444 citations), Cardiology and Cardiovascular Medicine (508 citations) and Nephrology (155 citations). Xue Tian has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shuohua Chen, Shouling Wu, Yingting Zuo, Anxin Wang, Anxin Wang, Penglian Wang, Yijun Zhang, Qin Xu, Xiaoli Zhang and Yongjun Wang. Their work appears in journals such as PLoS ONE, Neurology and Stroke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.